Gaurav S. Iyer,IFC

Gaurav S. Iyer is a research analyst and editor at Lombardi Financial. He currently writes for Profit Confidential where he focuses on macroeconomics and capital markets.

On the equity side, Iyer is a fundamental analyst who focuses on company business models and how those companies are positioned within their industry compared to their competitors. His economic research and analysis has appeared in The Economist.

Iyer co-founded the Rethinking Economic chapters in Toronto and Montreal, Canada.

Get to know Gaurav…

What was your very first investment?

My older brother had saved a nest egg and wanted to invest, so he asked for my help. Finding ripe industries was easy since I already understood economics. This was in 2009, and I realized that financials were sure to rebound. But once I began looking at individual companies, I gained a new level of respect for how uniquely structured each firm could be, and what it meant about their potential for success or failure.

What has been the most memorable moment of your investment career?

My most memorable moment came from owning a large-cap tech company. It was an over-hyped stock that was straining under a heavy load of pessimism. Those are the moments that define successful investors. I did not listen to the naysayers; I trusted my analysis, and a year later the stock had earned 30%.

What is your investment philosophy?

I am a value investor. I think of companies, not stocks. It helps me to know where exactly a business is making its money, how it plans to expand, and whether it can defend its market share. Only once you know those things can you determine if the stock is over- or under-priced.

Gaurav S. Iyer's Articles

Cryptocurrency News On the whole, cryptocurrency prices are down from our previous report on cryptos, with the market slipping on news of an exchange being hacked and a report about Bitcoin manipulation. However, there have been two bright spots: 1) an official from the U.S. Securities and Exchange…

Trump on Marijuana Stocks In the past two weeks, President Donald Trump squabbled with G7 allies and traversed half the globe to negotiate with the “Little Rocket Man” of North Korea. But, believe it or not, we’re most interested in something he said before any of that happened.…

Bill C-45 Inches Closer to Completion Last week, investors were jumpy over Canada’s path to nationwide pot legalization—but it turns out they needn’t have worried. Before we get into Canada’s political battles of cannabis and how it affects marijuana stocks, I want to address why we’re talking about…

Why AXON Stock Surged by 315% When a stock explodes upward, it draws the eyes of every analyst and trader. We watch its ascent, spellbound and eager to ride the wave. But what happens when the fuel runs dry? That’s the question we’re asking about Axovant Sciences Ltd…

The Story of TGOD Stock, According to Its CEO For the last year, marijuana stocks were the hot new destination for investment capital. But as they became overcrowded with speculation and hype, investors started to look for hidden gems: the rare, valuable, hard-to-find stocks that can turn rags…

Ripple vs SWIFT: The War Begins While most criticisms of XRP do nothing to curb my bullish Ripple price forecast, there is one obstacle that nags at my conscience. Its name is SWIFT. The Society for Worldwide Interbank Financial Telecommunication (SWIFT) is the king of international payments. It…

Why LXRP Stock Is Surging Earlier in the year, regulators at the U.S. Food and Drug Administration (FDA) opened the door to a new age of cannabidiol treatment—in which companies like Lexaria Bioscience Corp (OTCMKTS:LXRP, CNSX:LXX) strip down medical marijuana to purer forms of treatment. What does this…

Shareholder Vote Could Dethrone Musk “Our culture has become so obsessed with celebrity that it’s easy to confuse fame with success,” writes Daniel Rodriguez, author of Rise: A Soldier, a Dream, and a Promise Kept. “They are not the same thing.” I keep thinking about this quote in…

Big Alcohol: Boon or Curse for Small Marijuana Stocks? Recently, a top marijuana CEO sat down with me to talk about the future of the business. In our little chat, he said something very interesting, namely, that cannabis “is not a commodity business; it’s a CPG business.” (CPG…

Why CARA Stock Spiked Investors got a big surprise earlier this month when Cara Therapeutics Inc (NASDAQ:CARA) announced a new distribution channel for the "Korsuva" drug, which is currently pending approval from the U.S. Food and Drug Administration (FDA). The reaction was huge. CARA stock soared by nearly 43%…

Trouble with the Qualcomm NXP Merger If you’re in business, the most dangerous combination in the world is President Donald Trump and China. Unfortunately, that’s exactly what QUALCOMM, Inc. (NASDAQ:QCOM) finds itself facing, much to the chagrin of QCOM stockholders who worry about the pending Qualcomm NXP merger. The timing…

MedMen Stock Comes to Canada On May 29, MedMen Enterprises Inc. (CSE:MMEN) used a silent backdoor to enter the stock market. It’s called a “reverse takeover” (RTO). Most investors have never heard of this tricky financial maneuver, but it has big implications for MedMen stock and MedMen’s valuation. Before we…

PYPL Stock Is a Silent Goldmine Given the rise of financial technology (fintech) over the past few years, retail investors should have taken a closer look at PayPal Holdings Inc (NASDAQ:PYPL). Too bad Bitcoin (BTC) was in the way. It's no one's fault, really. Bitcoin and other cryptocurrencies…

Sunniva Q1 Earnings 2018 Sunniva Inc (OTCMKTS:SNNVF, CNSX:SNN) is not a household name by any stretch of the imagination. It is not even a semi-popular name. And yet I’ve been waiting for Sunniva Q1 earnings with bated breath—I even marked it on my calendar, something I don’t do for…

Is Aurora Stock Undervalued? With the CanniMed Therapeutics Inc (OTCMKTS:CMMDF, TSE:CMED) and MedReleaf Corp (OTCMKTS:MEDFF, TSE:LEAF) acquisitions coming to a close, Aurora Cannabis Inc (OTCMKTS:ACBFF, TSE:ACB) is poised to become the biggest weed stock in the world. Unfortunately, no one seems to care. Investors have all but abandoned…

Trust Is Growing... Before we get to this week’s cryptocurrency news, analysis, and our cryptocurrency price forecast, I want to share an experience from this past week. I was at home watching the NBA playoffs, trying to ignore the commercials, when a strange advertisement caught my eye. It…

What Happened in Brussels Remember when Facebook, Inc. (NASDAQ:FB) squared off against Congress? The FB stock price dropped a few percent afterward, as investors considered the dangers of regulation. It turns out they needn’t have worried, though, because American regulators aren’t the problem. European regulators are the real…

Why Symantec Stock Crashed When Symantec Corporation (NASDAQ:SYMC) published its most recent earnings report, the results were surprising. Symantec beat expectations on sales and profit, yet its share price collapsed by more than 33%. Naturally, investors are curious as to why Symantec stock crashed. Hint: It has something…